A randomised controlled clinical trial to evaluate the efficacy of rutu Haritaki in Dyslipidemia in Shishir rutu

Elevated plasmacholesterol levels are a major risk factor for cardiovascular diseases.Atherosclerotic plaque formation is an inflammatory process in the endothelialvessel wall associated with retained low-density lipoprotein (LDL). Strategiesto combat elevated cholesterol levels include lifestyle changes andpharmacological interventions.

Drug treatment of high blood lipids isnecessary to reduce cardiovascular risk and prevent heart attacks, strokes,high blood pressure, fatty liver disease, diabetes, among people with thiscondition. To prevent & cure these diseases Rutu Haritaki can act effectivelyas Rasayan by balancing vitiation of dosha. Haritaki is advocated for allseasons along with specific Anupan in Bhavprakash Samhita to balancephysiological variations of dosha due to seasonal changes.In shishir rutu saccumulation of Kapha dosha takes place.

Acharya Bhavamishra stated that Haritaki shouldbe taken with the adjuvant Pippali in Shishir Rutu. Pippali  pacifieskaphadosha. Haritiki & Pippali both pacifies kapha Vata dosha. ThusHaritaki along with Pippali in Shishir Rutu maintains equilibrium of tridosha.Excessive accumulation of kapha dosha can lead to increase in Medadhatu. Currently available hypolipidemic drugs have been associated with anumber of side effects.Properties of Haritaki as mentioned in samhita is havingpredominance of Kashaya Rasa & Ushnaveerya. Due to these properties itcauses reduction in Medodushti. Hence Haritaki can be used to reducedyslipidemia. Hence this study is selected.

Patient with abnormal lipid profile and agedbetween 40 to 60 years will be selected. Study drug & control Drug will beprovided to the patient in two groups for 60 days. Assessment will be done bysubjective & objective parameters. Analysis will be done. Conclusion willbe drawn.